NIH-funded research NIH-funded research

A partnership to improve heart failure treatment and clinical trials.

Official title: The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community

Funded at Inova Health Care Services · NIH-10823250 · Data updated 2026-11-12

The Heart Failure Collaboratory is working together with patients, researchers, and industry experts to make it easier and faster to develop new treatments for heart failure, so that people living with this condition can have better options and outcomes.

More Heart Failure research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionInova Health Care Services
NIH-funded
Lab location1 site (Fairfax, UNITED STATES)
Project startApril 10, 2020
Project endMarch 31, 2026
Funding year2024
Award (this year)$50,000
NIH project number5R18FD006920-05
Project IDNIH-10823250 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with heart failure who are interested in participating in clinical trials or benefiting from new treatment developments.

Less likely to help

Patients with conditions unrelated to heart failure may not receive any benefit from this research.

What this research studies

The Heart Failure Collaboratory (HFC) is a collaboration between the Inova Heart and Vascular Institute, the FDA, and various stakeholders in the heart failure community. This initiative aims to enhance the efficiency of clinical trials and the development of new therapies for heart failure by fostering collaboration among patients, researchers, and industry representatives. The HFC focuses on addressing challenges in the heart failure ecosystem, such as refining clinical trial endpoints and standardizing data collection. By creating a supportive environment for innovation, the HFC seeks to improve patient outcomes and accelerate the introduction of effective treatments.

Why it matters

Potential benefit: If successful, this research could lead to more effective heart failure therapies and improved clinical trial processes.

How similar studies have gone: Other collaborative efforts in the medical field have shown success in improving clinical trial efficiency and therapeutic development, indicating a promising approach.

Where this research is happening

  • Inova Health Care Services
    Fairfax, United States
    Active

Researchers

  • Principal investigator: O'connor, Christopher M — Inova Health Care Services
  • Study coordinator: O'connor, Christopher M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.